Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:42 PM
Ignite Modification Date:
2025-12-24 @ 10:42 PM
NCT ID:
NCT02044835
Eligibility Criteria:
Inclusion Criteria:
1. Met the ARAS diagnosis: renal angiography or magnetic resonance angiography (MRA) shows renal artery with unilateral or bilateral stenosis at least 50%，and with artery atheromatous plague;
2. Meeting with the diagnostic criteria of the K/DOQI chronic kidney disease （eGFR\<90ml/min）：light or moderate damage to kidney function，Scr\<265.2µmol/L(3.0mg/dl).
Exclusion Criteria:
1. Patients with renal artery stenosis which had been suspected or final diagnosed to be Fibromuscular dysplasia or Takayasu arteritis;
2. Blood pressure did not meet the target (\<140/90mmHg) after combinedly taking more three kinds of antihypertensive agents with maximum dose;
3. Poor control of blood sugar in patients with Diabetes ( glycosylated hemoglobin 8.0% or higher in the recent month);
4. History of peptic ulcer，with Gastrointestinal bleeding in the recent 6 months;
5. decompensated cirrhosis;
6. Hematologic disease or bleeding tendency;
7. Repeated episodes of pulmonary edema, congestive heart failure, acute myocardial infarction, cerebral infarction and cerebral hemorrhage in recent 3 months;
8. Suffering from malignant tumor and predicting life span less than 1 year.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02044835
Study Brief:
Protocol Section:
NCT02044835